![]() |
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features |
| Twitter ~ Facebook |
|
Home
/ Technology News / 2009 / October 2009 / October 23, 2009 |
Marathon training causes heart damage in healthy people
Loneliness linked to high BP in elderly
Increased intake of leafy greens, nuts can cut colon cancer risk in men
Sperm of ants battle inside the queens
Leafcutter ant queens shut down male-male sperm competition
Two novel ways to kill TB discovered
Scientists have discovered two novel ways of killing the bacteria that cause tuberculosis (TB). ANI
Gene linked to lung cancer in non-smokers identified
Scientists have identified a gene that is specifically associated with lung cancer in people who have never smoked. ANI
Doublesex gene determines fruit fly gender
Doublesex (dsx) gene in fruit fly, not only determines the shape and structure of the male and female body, but also moulds the architecture of their brain and nervous system, resulting in sex-specific behaviours, according to a study from the Glasgow University and Oxford. ANI
Scientists have created a revolutionary once-a-day jab that can fight obesity.
London, Oct 23 : Scientists have created a revolutionary once-a-day jab that can fight obesity.
Liraglutide not only controls the symptoms of diabetes but also leads to significant weight loss.
Earlier this year, the super drug was given the go-ahead by European regulators. And now, latest tests have shown it to be significantly more effective than fat pills.
In study trials, the jab has shown promise in helping people lose weight by increasing the "full" feeling after eating and by slowing the speed at which their stomach empties, reports The Daily Express.
What's more, it lowers blood pressure, a major factor in the development of heart disease.
In the study by Professor Arne Astrup, of the University of Copenhagen, published in The Lancet, high doses of liraglutide were found to lead to greater weight loss than the prescription-only drug orlistat.
The authors said: "The results indicate the potential benefit of liraglutide, in conjunction with an energy-deficit diet, in the treatment of obesity."
Obesity expert Professor Steve Bloom, of Imperial College London, said: "At last science is providing treatments that work in obesity. As we all are dying earlier from our excessive fat, this is a breakthrough."
ANI